Brighthouse Financial, Inc. (BHF) Financial Statements
Brighthouse Financial, Inc. (BHF) reported trailing twelve-month revenue of $6.7B (up 2.6% year on year) and net income of $831.0M as of 2026-06-30, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
BHFBrighthouse Financial, Inc.Follow BHF — free
—
Price chart with a free account
- Market cap
- 2.6B
- P/E TTM
- 3.6
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 11 Nov, in 18 days
Fiscal-year columns end in the month shown. The current fiscal year appears once its annual report is filed; until then TTM = the last four reported quarters, to Jun 26.
| Line | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 6.84 | 8.97 | 6.55 | 8.50 | 4.98 | 6.87 | 4.12 | 4.72 | 6.77 | 6.65 | |
| Pre-tax income | -0.62 | 0.99 | -1.05 | -1.42 | 2.01 | 4.73 | -1.47 | 0.42 | 0.47 | 0.98 | |
| Income tax | -0.24 | 0.12 | -0.32 | -0.36 | 0.36 | 0.85 | -0.37 | 0.03 | 0.04 | 0.14 | |
| Net income | -0.38 | 0.87 | -0.74 | -1.06 | 1.64 | 3.88 | -1.11 | 0.39 | 0.43 | 0.83 | |
| Diluted EPS ($) | — | 7.21 | -6.76 | -11.58 | 18.39 | 51.30 | -18.39 | 4.64 | 5.71 | 12.53 | |
| Diluted shares (bn) | — | 0.120 | 0.113 | 0.095 | 0.084 | 0.074 | 0.066 | 0.062 | 0.058 | — |
USD billions · SEC XBRL
Brighthouse Financial, Inc. — questions
- What is Brighthouse Financial, Inc.'s revenue?
- $6.7B over the twelve months to 2026-06-30, up 2.6% year on year, from its 10-Q and 10-K filings.
- What is Brighthouse Financial, Inc.'s net income?
- $831.0M over the twelve months to 2026-06-30.
- What are Brighthouse Financial, Inc.'s diluted earnings per share?
- $12.53 over the twelve months to 2026-06-30.
Every figure on this page comes from Brighthouse Financial, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.